Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian White

Sports Medicine Englewood, CO Medical Doctor

NPI 1477743466 CMS profile 66368

500 E Hampden Ave Ste 400, Englewood, CO 80113

Open in the dashboard

General payments

$197,134

171 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$20,375 paid to institutions, not to them · program year 2021

Through program year 2025, Brian White of Englewood, CO is reported in the CMS Open Payments database as having received $197,134 across 171 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $20,375 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,913 14
2024 General $18,384 20
2023 General $21,765 28
2022 General $32,119 26
2021 General $34,149 21
2020 General $24,594 18
2019 General $57,210 44

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian White
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Brian White were reported at $8,913. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Brian White Sports Medicine median Middle half National median
2019 $57,210 $1,176 $199–$4,249 $163
2020 $24,594 $708 $96–$2,890 $114
2021 $34,149 $1,213 $152–$3,994 $132
2022 $32,119 $1,230 $159–$3,998 $149
2023 $21,765 $584 $146–$2,836 $160
2024 $18,384 $628 $163–$3,168 $164
2025 $8,913 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $156,936 122 payments
  2. Zimmer Biomet Holdings, Inc. $38,891 47 payments
  3. Gemini Mountain Medical, LLC $1,307 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $150,178 67 payments
  2. Royalty or License $27,891 36 payments
  3. Consulting Fee $13,610 13 payments
  4. Food and Beverage $2,837 45 payments
  5. Travel and Lodging $1,419 9 payments
  6. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. ACCUPASS DIRECT Crescent XL $46,356 26 payments
  2. Bioraptor Knotless $30,825 24 payments
  3. Osteoraptor $28,925 18 payments
  4. Suturefix $25,054 20 payments
  5. Q-FIX Extremities & Limb Restoration $24,018 11 payments
  6. SPEEDLOCK HIP $22,065 21 payments
  7. CAP-FIX $21,504 9 payments
  8. Q-FIX Hip $19,163 7 payments
  9. Q-FIX Sports Med Hip $17,628 19 payments
  10. MICRORAPTOR $15,282 8 payments
  11. Other $325,446 243 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

28

Median for Orthopedic Surgery: 203

Drug cost

$68

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 28 $68

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$43,277

Medicare's payments for the services billed

Medicare patients

107

Average age 68

Services billed

298

80 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 71%
High blood pressure 43%
Depression 29%
Osteoporosis 26%
Ischemic heart disease 16%
Diabetes 12%
Chronic kidney disease 12%
COPD 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

171 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record